SG11201605532YA - Pyridylaminoacetic acid compound and polyoxyethylene castor oil-containing pharmaceutical composition - Google Patents
Pyridylaminoacetic acid compound and polyoxyethylene castor oil-containing pharmaceutical compositionInfo
- Publication number
- SG11201605532YA SG11201605532YA SG11201605532YA SG11201605532YA SG11201605532YA SG 11201605532Y A SG11201605532Y A SG 11201605532YA SG 11201605532Y A SG11201605532Y A SG 11201605532YA SG 11201605532Y A SG11201605532Y A SG 11201605532YA SG 11201605532Y A SG11201605532Y A SG 11201605532YA
- Authority
- SG
- Singapore
- Prior art keywords
- pharmaceutical composition
- castor oil
- acid compound
- polyoxyethylene castor
- containing pharmaceutical
- Prior art date
Links
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
- A61K31/44—Non condensed pyridines; Hydrogenated derivatives thereof
- A61K31/4427—Non condensed pyridines; Hydrogenated derivatives thereof containing further heterocyclic ring systems
- A61K31/444—Non condensed pyridines; Hydrogenated derivatives thereof containing further heterocyclic ring systems containing a six-membered ring with nitrogen as a ring heteroatom, e.g. amrinone
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
- A61K47/02—Inorganic compounds
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
- A61K47/06—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite
- A61K47/08—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite containing oxygen, e.g. ethers, acetals, ketones, quinones, aldehydes, peroxides
- A61K47/12—Carboxylic acids; Salts or anhydrides thereof
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
- A61K47/06—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite
- A61K47/16—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite containing nitrogen, e.g. nitro-, nitroso-, azo-compounds, nitriles, cyanates
- A61K47/18—Amines; Amides; Ureas; Quaternary ammonium compounds; Amino acids; Oligopeptides having up to five amino acids
- A61K47/183—Amino acids, e.g. glycine, EDTA or aspartame
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
- A61K47/44—Oils, fats or waxes according to two or more groups of A61K47/02-A61K47/42; Natural or modified natural oils, fats or waxes, e.g. castor oil, polyethoxylated castor oil, montan wax, lignite, shellac, rosin, beeswax or lanolin
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/0012—Galenical forms characterised by the site of application
- A61K9/0048—Eye, e.g. artificial tears
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/08—Solutions
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P27/00—Drugs for disorders of the senses
- A61P27/02—Ophthalmic agents
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P27/00—Drugs for disorders of the senses
- A61P27/02—Ophthalmic agents
- A61P27/06—Antiglaucoma agents or miotics
-
- Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
- Y02—TECHNOLOGIES OR APPLICATIONS FOR MITIGATION OR ADAPTATION AGAINST CLIMATE CHANGE
- Y02A—TECHNOLOGIES FOR ADAPTATION TO CLIMATE CHANGE
- Y02A50/00—TECHNOLOGIES FOR ADAPTATION TO CLIMATE CHANGE in human health protection, e.g. against extreme weather
- Y02A50/30—Against vector-borne diseases, e.g. mosquito-borne, fly-borne, tick-borne or waterborne diseases whose impact is exacerbated by climate change
Landscapes
- Health & Medical Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Veterinary Medicine (AREA)
- General Health & Medical Sciences (AREA)
- Medicinal Chemistry (AREA)
- Public Health (AREA)
- Pharmacology & Pharmacy (AREA)
- Animal Behavior & Ethology (AREA)
- Epidemiology (AREA)
- Chemical Kinetics & Catalysis (AREA)
- General Chemical & Material Sciences (AREA)
- Engineering & Computer Science (AREA)
- Oil, Petroleum & Natural Gas (AREA)
- Ophthalmology & Optometry (AREA)
- Organic Chemistry (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Proteomics, Peptides & Aminoacids (AREA)
- Inorganic Chemistry (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Medicinal Preparation (AREA)
Applications Claiming Priority (2)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
JP2014002809 | 2014-01-10 | ||
PCT/JP2015/050333 WO2015105134A1 (ja) | 2014-01-10 | 2015-01-08 | ピリジルアミノ酢酸化合物とポリオキシエチレンヒマシ油含有医薬組成物 |
Publications (1)
Publication Number | Publication Date |
---|---|
SG11201605532YA true SG11201605532YA (en) | 2016-08-30 |
Family
ID=53523959
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
SG11201605532YA SG11201605532YA (en) | 2014-01-10 | 2015-01-08 | Pyridylaminoacetic acid compound and polyoxyethylene castor oil-containing pharmaceutical composition |
Country Status (19)
Country | Link |
---|---|
US (3) | US20160317512A1 (ja) |
EP (2) | EP3888654B1 (ja) |
JP (5) | JP6012775B2 (ja) |
KR (6) | KR102111157B1 (ja) |
CN (2) | CN110251516B (ja) |
AU (1) | AU2015205268B2 (ja) |
BR (1) | BR112016015911B1 (ja) |
CA (1) | CA2934612C (ja) |
EA (1) | EA031723B1 (ja) |
ES (2) | ES2953346T3 (ja) |
GE (1) | GEP20186916B (ja) |
HK (1) | HK1224191A1 (ja) |
IL (1) | IL246654B (ja) |
MX (1) | MX2016009058A (ja) |
MY (1) | MY166210A (ja) |
PH (1) | PH12016501327A1 (ja) |
SG (1) | SG11201605532YA (ja) |
TW (1) | TWI612960B (ja) |
WO (1) | WO2015105134A1 (ja) |
Families Citing this family (10)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
KR102111157B1 (ko) * | 2014-01-10 | 2020-05-14 | 산텐 세이야꾸 가부시키가이샤 | 피리딜아미노아세트산 화합물과 폴리옥시에틸렌 피마자유를 함유하는 의약 조성물 |
CN105828818B (zh) | 2014-01-10 | 2020-06-02 | 参天制药株式会社 | 含有吡啶基氨基乙酸化合物的药物组合物 |
CN105899209B (zh) | 2014-01-10 | 2018-09-11 | 参天制药株式会社 | 含有吡啶基氨基乙酸化合物的药物制剂 |
ES2950461T3 (es) | 2015-07-09 | 2023-10-10 | Santen Pharmaceutical Co Ltd | Agente preventivo y/o terapéutico que contiene un compuesto de ácido piridilaminoacético para el tratamiento de una enfermedad que involucra una presión intraocular muy elevada |
CA3067332A1 (en) | 2017-06-16 | 2018-12-20 | The Doshisha | Mtor-inhibitor-containing medicine for treating or preventing ophthalmic symptoms, disorders, or diseases, and application thereof |
US20200121652A1 (en) | 2017-06-16 | 2020-04-23 | The Doshisha | Compounds having caspase inhibitory activity, pharmaceutical agent containing said compounds and for treating or preventing corneal endothelial symptoms, disorders, or diseases, and application of said pharmaceutical agent |
EP3689349A4 (en) | 2017-09-29 | 2021-06-23 | Santen Pharmaceutical Co., Ltd. | MEDICINAL PRODUCT CONTAINING A COMPOUND OF PYRIDYLAMINOACETIC ACID |
CA3086445A1 (en) | 2017-12-21 | 2019-06-27 | Santen Pharmaceutical Co., Ltd. | Omidenepag combination |
WO2019131901A1 (ja) | 2017-12-28 | 2019-07-04 | 参天製薬株式会社 | ピリジルアミノ酢酸化合物を含有する医薬製剤 |
WO2021107033A1 (ja) * | 2019-11-29 | 2021-06-03 | 千寿製薬株式会社 | 医薬組成物 |
Family Cites Families (18)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US4960799A (en) * | 1988-09-13 | 1990-10-02 | Ciba-Geigy Corporation | Stabilized aqueous solutions of pharmaceutically acceptable salts of ortho-(2,6-dichlorophenyl)-aminophenylacetic acid for opthalmic use |
US5631287A (en) * | 1994-12-22 | 1997-05-20 | Alcon Laboratories, Inc. | Storage-stable prostaglandin compositions |
JP3297969B2 (ja) * | 1994-12-26 | 2002-07-02 | ライオン株式会社 | 点眼剤 |
US6235781B1 (en) * | 1998-07-14 | 2001-05-22 | Alcon Laboratories, Inc. | Prostaglandin product |
AU743607B2 (en) * | 1998-07-14 | 2002-01-31 | Alcon Laboratories, Inc. | Prostaglandin product |
US20020009507A1 (en) * | 2000-01-19 | 2002-01-24 | Alcon Universal Ltd. | Use of polyethoxylated castor oil for the treatment of dry eye |
JP2002356420A (ja) * | 2001-03-27 | 2002-12-13 | Santen Pharmaceut Co Ltd | 安定な水性液剤 |
PT2264009T (pt) | 2008-03-12 | 2019-04-29 | Ube Industries | Composto do ácido piridilaminoacético |
PL2415763T3 (pl) * | 2009-03-30 | 2016-05-31 | Ube Industries | Kompozycja farmaceutyczna do leczenia lub profilaktyki jaskry |
JP2011057633A (ja) * | 2009-09-11 | 2011-03-24 | Ube Industries Ltd | ピリジルアミノ酢酸化合物を含有する医薬 |
US20120058983A1 (en) * | 2010-09-02 | 2012-03-08 | Bayer Pharma Aktiengesellschaft | Adenosine A1 agonists for the treatment of glaucoma and ocular hypertension |
US9339496B2 (en) * | 2012-07-13 | 2016-05-17 | Santen Pharmaceutical Co., Ltd. | Composition for treating or preventing glaucoma comprising a sulfonamide compound, and a beta-receptor antagonist |
WO2014010654A2 (ja) * | 2012-07-13 | 2014-01-16 | 参天製薬株式会社 | スルホンアミド化合物の組み合わせ |
US20140018350A1 (en) * | 2012-07-13 | 2014-01-16 | Asahi Glass Co., Ltd. | Combination of sulfonamide compound and tafluprost |
JP2014019650A (ja) * | 2012-07-13 | 2014-02-03 | Santen Pharmaceut Co Ltd | スルホンアミド化合物とタフルプロストの組み合わせ |
KR102111157B1 (ko) * | 2014-01-10 | 2020-05-14 | 산텐 세이야꾸 가부시키가이샤 | 피리딜아미노아세트산 화합물과 폴리옥시에틸렌 피마자유를 함유하는 의약 조성물 |
CN105899209B (zh) * | 2014-01-10 | 2018-09-11 | 参天制药株式会社 | 含有吡啶基氨基乙酸化合物的药物制剂 |
CN105828818B (zh) * | 2014-01-10 | 2020-06-02 | 参天制药株式会社 | 含有吡啶基氨基乙酸化合物的药物组合物 |
-
2015
- 2015-01-08 KR KR1020187012966A patent/KR102111157B1/ko active IP Right Grant
- 2015-01-08 CN CN201910493497.8A patent/CN110251516B/zh active Active
- 2015-01-08 JP JP2015002271A patent/JP6012775B2/ja active Active
- 2015-01-08 BR BR112016015911-0A patent/BR112016015911B1/pt active IP Right Grant
- 2015-01-08 ES ES21174649T patent/ES2953346T3/es active Active
- 2015-01-08 MX MX2016009058A patent/MX2016009058A/es unknown
- 2015-01-08 WO PCT/JP2015/050333 patent/WO2015105134A1/ja active Application Filing
- 2015-01-08 KR KR1020227036348A patent/KR102675685B1/ko active IP Right Grant
- 2015-01-08 TW TW104100527A patent/TWI612960B/zh active
- 2015-01-08 SG SG11201605532YA patent/SG11201605532YA/en unknown
- 2015-01-08 EP EP21174649.0A patent/EP3888654B1/en active Active
- 2015-01-08 KR KR1020217007751A patent/KR102458180B1/ko active IP Right Grant
- 2015-01-08 KR KR1020207013304A patent/KR102230683B1/ko active IP Right Grant
- 2015-01-08 KR KR1020247019428A patent/KR20240096869A/ko not_active Application Discontinuation
- 2015-01-08 ES ES15735607T patent/ES2874547T3/es active Active
- 2015-01-08 CA CA2934612A patent/CA2934612C/en active Active
- 2015-01-08 MY MYPI2016001268A patent/MY166210A/en unknown
- 2015-01-08 AU AU2015205268A patent/AU2015205268B2/en active Active
- 2015-01-08 EA EA201691139A patent/EA031723B1/ru unknown
- 2015-01-08 KR KR1020167016400A patent/KR101858373B1/ko active IP Right Grant
- 2015-01-08 EP EP15735607.2A patent/EP3093021B1/en active Active
- 2015-01-08 CN CN201580003056.5A patent/CN105828817B/zh active Active
- 2015-01-08 GE GEAP201514216A patent/GEP20186916B/en unknown
-
2016
- 2016-07-04 PH PH12016501327A patent/PH12016501327A1/en unknown
- 2016-07-07 US US15/204,475 patent/US20160317512A1/en not_active Abandoned
- 2016-07-07 IL IL246654A patent/IL246654B/en active IP Right Grant
- 2016-09-16 JP JP2016181739A patent/JP6449205B2/ja active Active
- 2016-10-28 HK HK16112476.0A patent/HK1224191A1/zh unknown
-
2018
- 2018-12-05 JP JP2018227964A patent/JP6793172B2/ja active Active
-
2019
- 2019-12-12 US US16/711,706 patent/US20200113880A1/en not_active Abandoned
-
2020
- 2020-11-09 JP JP2020186245A patent/JP7170020B2/ja active Active
-
2022
- 2022-10-31 JP JP2022174719A patent/JP7546027B2/ja active Active
-
2023
- 2023-08-02 US US18/363,961 patent/US20230372316A1/en active Pending
Also Published As
Similar Documents
Publication | Publication Date | Title |
---|---|---|
HK1224191A1 (zh) | 含有吡啶基氨基乙酸化合物和聚氧乙烯蓖麻油的藥物組合物 | |
IL252477A0 (en) | 2-aminopyrimidine compound, pharmaceutical structure and its use | |
IL253123A0 (en) | Preparations for administration through the skin and their uses | |
HK1225655A1 (zh) | 包含azd9291的藥用組合物 | |
EP3102200A4 (en) | Therapeutic compounds and compositions | |
IL246447A0 (en) | A pharmaceutical preparation containing a pyridylaminoacetic acid compound | |
IL246655A0 (en) | A medical preparation containing a pyridyl amino acetic acid compound | |
EP3102585A4 (en) | Boronic acid esters and pharmaceutical formulations thereof | |
ZA201703976B (en) | Dihydropyrimidine-2-one compounds and medicinal uses thereof | |
EP3149099A4 (en) | Synthetic acid compositions and uses thereof | |
ZA201703398B (en) | Pharmaceutical composition and methods | |
PT3202759T (pt) | Derivado de alfa-aminoamida e composição farmacêutica contendo o mesmo | |
EP3139741A4 (en) | Methods and compositions comprising 10-hydroxy-2-decenoic acid | |
PL3184492T3 (pl) | Preparat antyseptyczny | |
IL250729A0 (en) | A pyrazolothiazole compound and a drug containing it | |
GB201417589D0 (en) | Pharmaceutical Formulations | |
SG11201700122TA (en) | Pharmaceutical compound comprising 13 glycerides, formulation and application thereof | |
GB201511863D0 (en) | Pharmaceutical compositions comprising hexaminolevulnic acid and methods of using the same |